Clinical Trial Update: Cilostazol for Preventing Delayed Cerebral Ischemia in Aneurysmal Subarachnoid Hemorrhage [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating whether cilostazol can prevent delayed cerebral ischemia after an aneurysmal subarachnoid hemorrhage; the study is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aneurysmal Subarachnoid Hemorrhage

Drugs mentioned

• Cilostazol (Cilostazol)

Snippet

Sponsor: Beijing Tiantan Hospital | Conditions: Aneurysmal Subarachnoid Hemorrhage | Phase 3 | Status: NOT_YET_RECRUITING